CORC

在结果中检索

CORC

浏览/检索结果: 共38条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
First result from the Jinping Underground Nuclear Astrophysics experiment JUNA: precise measurement of the 92 keV Mg-25(p, y)Al-26 resonance 期刊论文
SCIENCE BULLETIN, 2022, 卷号: 67, 期号: 2, 页码: 125-132
作者:  Su, Jun;  Zhang, Hao;  Li, Zhihong;  Ventura, Paolo;  Li, Yunju
收藏  |  浏览/下载：28/0  |  提交时间：2022/04/11
Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results 期刊论文
HEPATOLOGY INTERNATIONAL, 2019, 卷号: 13, 期号: 3
作者:  Liang, Xieer;  Gao, Zhiliang;  Xie, Qing;  Zhang, Jiming;  Sheng, Jifang
收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05
Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China 期刊论文
BMC GASTROENTEROLOGY, 2019, 卷号: 19
作者:  Sun, Jian;  Ding, Huiguo;  Chen, Guofeng;  Wang, Guiqiang;  Wei, Lai
收藏  |  浏览/下载：41/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 期刊论文
HEPATOLOGY, 2018, 卷号: 68
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：21/0  |  提交时间：2019/12/05
Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B 期刊论文
HEPATOLOGY RESEARCH, 2018, 卷号: 48, 期号: 3
作者:  Yu, Rui;  Tan, Deming;  Ning, Qin;  Niu, Junqi;  Bai, Xuefan
收藏  |  浏览/下载：28/0  |  提交时间：2019/12/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：11/0  |  提交时间：2019/11/19
Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B 期刊论文
HEPATOLOGY RESEARCH, 2018, 卷号: 48, 期号: 3
作者:  Yu, Rui;  Tan, Deming;  Ning, Qin;  Niu, Junqi;  Bai, Xuefan
收藏  |  浏览/下载：26/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace